Theseus Pharmaceuticals Statistics
Total Valuation
PCOK has a market cap or net worth of 178.31 million. The enterprise value is 1.01 billion.
| Market Cap | 178.31M |
| Enterprise Value | 1.01B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
PCOK has 102.95 million shares outstanding. The number of shares has decreased by -0.48% in one year.
| Current Share Class | 102.95M |
| Shares Outstanding | 102.95M |
| Shares Change (YoY) | -0.48% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 6.08% |
| Float | 100.45M |
Valuation Ratios
| Price/FFO Ratio | n/a |
| Price/AFFO Ratio | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.94 |
| PB Ratio | 1.31 |
| P/TBV Ratio | 1.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -22.78 |
| EV / Sales | 10.95 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.22, with a Debt / Equity ratio of 6.28.
| Current Ratio | 0.22 |
| Quick Ratio | 0.12 |
| Debt / Equity | 6.28 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -0.64 |
Financial Efficiency
Return on equity (ROE) is -29.60% and return on invested capital (ROIC) is -2.70%.
| Return on Equity (ROE) | -29.60% |
| Return on Assets (ROA) | -2.50% |
| Return on Invested Capital (ROIC) | -2.70% |
| Return on Capital Employed (ROCE) | -6.63% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.08 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, PCOK has paid 10.89 million in taxes.
| Income Tax | 10.89M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.51% in the last 52 weeks. The beta is -119.45, so PCOK's price volatility has been lower than the market average.
| Beta (5Y) | -119.45 |
| 52-Week Price Change | -50.51% |
| 50-Day Moving Average | 4.02 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 32.90 |
| Average Volume (20 Days) | 4,687 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.23 |
Income Statement
In the last 12 months, PCOK had revenue of 91.86 million and -44.16 million in losses. Loss per share was -0.43.
| Revenue | 91.86M |
| Gross Profit | 1.51M |
| Operating Income | -45.80M |
| Pretax Income | -36.85M |
| Net Income | -44.16M |
| EBITDA | -8.40M |
| EBIT | -45.80M |
| Loss Per Share | -0.43 |
Balance Sheet
The company has 23.04 million in cash and 853.97 million in debt, giving a net cash position of -830.93 million or -8.07 per share.
| Cash & Cash Equivalents | 23.04M |
| Total Debt | 853.97M |
| Net Cash | -830.93M |
| Net Cash Per Share | -8.07 |
| Equity (Book Value) | 135.88M |
| Book Value Per Share | 1.35 |
| Working Capital | -299.91M |
Cash Flow
| Operating Cash Flow | -35.81M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 1.64%, with operating and profit margins of -49.86% and -48.08%.
| Gross Margin | 1.64% |
| Operating Margin | -49.86% |
| Pretax Margin | -40.12% |
| Profit Margin | -48.08% |
| EBITDA Margin | -9.14% |
| EBIT Margin | -49.86% |
| FCF Margin | n/a |
Dividends & Yields
PCOK does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.48% |
| Shareholder Yield | n/a |
| Earnings Yield | -24.77% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |